APA (7th ed.) Citation

Opal, S. M., Dellinger, R. P., Vincent, J., Masur, H., & Angus, D. C. (2014). The Next Generation of Sepsis Clinical Trial Designs: What Is Next After the Demise of Recombinant Human Activated Protein C?*. Critical Care Medicine, 42(7), 1714. https://doi.org/10.1097/CCM.0000000000000325

Chicago Style (17th ed.) Citation

Opal, Steven M., R. Phillip Dellinger, Jean-Louis Vincent, Henry Masur, and Derek C. Angus. "The Next Generation of Sepsis Clinical Trial Designs: What Is Next After the Demise of Recombinant Human Activated Protein C?*." Critical Care Medicine 42, no. 7 (2014): 1714. https://doi.org/10.1097/CCM.0000000000000325.

MLA (9th ed.) Citation

Opal, Steven M., et al. "The Next Generation of Sepsis Clinical Trial Designs: What Is Next After the Demise of Recombinant Human Activated Protein C?*." Critical Care Medicine, vol. 42, no. 7, 2014, p. 1714, https://doi.org/10.1097/CCM.0000000000000325.